Register Now
Why register?
 The leading web portal for pharmacy resources, news, education and careers March 22, 2018
Pharmacy Choice - Pharmacy News - March 22, 2018

Pharmacy News

Today's Pharmaceutical and Pharmacy News
Daily News Topic:

FDA News
3/22/18 - Charm Sciences Announces New NCIMS Approval to Protect the Nation's Milk
Today, Charm Sciences announced the National Conference on Interstate Milk Shipments approved the Charm ROSA SULF test to detect sulfonamides in raw milk. The approval was at the recommendation of the U.S. Food and Drug Administration based on their industry data evaluation. According to Bob Salter, Vice President of Regulatory Affairs at Charm Sci
3/21/18 - Alkem received USFDA approval for Minocycline HCL [India Infoline News Service]
Alkem has received approval for Minocycline Hydrochloride in the strengths of 65 mg and 115 mg, as per the USFDA website. Alkem is likely to benefit from this as there are only 3 generic players in these strengths. As on Q3FY18, Alkem has filed a total of 96 ANDAs and 1 new drug application with the US FDA.
3/21/18 - FDA Approves Genentechâ??s Lucentis (ranibizumab injection) 0.3 mg Prefilled Syringe for Diabetic Macular Edema and Diabetic Retinopathy
Genentech, a member of the Roche Group, today announced that the U.S. Food and Drug Administration approved the Lucentis ® 0.3 mg prefilled syringe as a new method of administering the medicine to treat all forms of diabetic retinopathy. In April 2017, Lucentis 0.3 mg became, and remains, the first and only FDA- approved medicine to treat all form
3/21/18 - FDA Program Promises More Transparency in NDA Approvals [Syrian Arab News Agency]
FDA hopes its new pilot program, the Clinical Data Summary Pilot, will help to enhance future drug development by sharing portions of clinical study reports, according to Janet Woodcock, MD, director of the Center for Drug Evaluation and Research, in a FDAVoice blog post. The agencys goal is to directly share complete summaries of clinical trial in
3/21/18 - Global biotherapeutics - FDA Approves Hizentra for the Treatment of Patients with Chronic Inflammatory Demyelinating Polyneuropathy
KING OF PRUSSIA- Global biotherapeutics leader CSL Behring today announced that the U.S. Food and Drug Administration approved Hizentra as the first and only subcutaneous immunoglobulin for the treatment of chronic inflammatory demyelinating polyneuropathy as maintenance therapy to prevent relapse of neuromuscular disability and impairment.
3/21/18 - Longhorn Vaccines and Diagnostics LLC receives de novo clearance by the U.S. Food and Drug Administration for PrimeStore® Molecular Transport Medium establishing a new class of microbial nucleic acid stabilization devices for molecular testing
--Longhorn Vaccines and Diagnostics LLC, a private pre-analytical systems and molecular solutions company, has received a clearance from the U.S. Food and Drug Administration for PrimeStore ® Molecular Transport Medium. FDA 510 clearance is a worldwide recognized standard in stringent, unbiased, and transparent regulatory review for medical device

Chain Drug Review
Chain Drug Review Magazine Chain Drug Review, established in 1978 and published 21 times a year, is recognized as the premier news publication serving the entire chain drug store industry.
Featured Article from Chain Drug Review:
AWP suit settlement appealed
The National Association of Chain Drug Stores has appealed a U.S. District Court’s approval of settlements in the First DataBank Inc. and Medi-Span Inc. lawsuit. »read more

Pharmacy News Index
  Drug Delivery Systems
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry


Legal & Practical Issues in Compounding Pharmacy
This lesson is supported by:
Men's Health in Older Adults: Benign Prostatic Hyperplasia and Erectile Dysfunction
This lesson is supported by:
Pharmacy Spanish
This lesson is supported by:

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...

Websites »
Copyright © 2018 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement